PubMed

Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.

Bakris GL, Berkwits M.

Ann Intern Med. 2008 Mar 4;148(5):400-1. No abstract available. PMID: 18316758 [PubMed - indexed for MEDLINE]Related articlesFree article

Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.

Waeber B.

J Hypertens Suppl. 2006 May;24(3):S19-27. Review.PMID: 16723862 [PubMed - indexed for MEDLINE]Related articles

[Newly diagnosed hypertensive. It calls for treatment immediately with a combination ]

[No authors listed]

MMW Fortschr Med. 2003 Nov 6;145(45):48. German. No abstract available. PMID: 14712787 [PubMed - indexed for MEDLINE]Related articles

Perindopril + indapamide: new preparation. Simple trick.

[No authors listed]

Prescrire Int. 1999 Dec;8(44):172-5.PMID: 11503814 [PubMed - indexed for MEDLINE]Related articles

[Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes]

Scheen AJ, Krzesinski JM.

Rev Med Liege. 2007 Oct;62(10):639-43. French. PMID: 18069576 [PubMed - indexed for MEDLINE]Related articles

Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage.

Laurent S.

J Hypertens Suppl. 2003 Jun;21(3):S11-8. Review.PMID: 12929470 [PubMed - indexed for MEDLINE]Related articles

[ADVANCE study: objectives, design and current status]

Chalmers J.

Drugs. 2003;63 Spec No 1:39-44. French. PMID: 12708881 [PubMed - indexed for MEDLINE]Related articles

Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.

Joannides R, Bellien J, Thurlure C, Iacob M, Abeel M, Thuillez C.

Am J Hypertens. 2008 Jun;21(6):679-84. Epub 2008 Apr 3.PMID: 18443573 [PubMed - indexed for MEDLINE]Related articles

What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?

Waeber B.

Expert Opin Pharmacother. 2005 Oct;6(13):2291-9.PMID: 16218889 [PubMed - indexed for MEDLINE]Related articles

ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.

Perkovic V, Joshi R, Patel A, Bompoint S, Chalmers J; ADVANCE Collaborative Group.

Blood Press. 2006;15(6):340-6.PMID: 17472024 [PubMed - indexed for MEDLINE]Related articles

New Premier study suggest Preterax as a first-line antihypertensive.

[No authors listed]

Cardiovasc J S Afr. 2004 Jan-Feb;15(1):40-1. No abstract available. PMID: 15095752 [PubMed - indexed for MEDLINE]Related articlesFree article

[Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information]

Nilsson PM.

Lakartidningen. 2007 Oct 17-23;104(42):3028-9. Swedish. No abstract available. PMID: 17985709 [PubMed - indexed for MEDLINE]Related articles

[Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?]

Holzgreve H.

MMW Fortschr Med. 2007 Sep 20;149(38):19. German. No abstract available. PMID: 18018408 [PubMed - indexed for MEDLINE]Related articles

Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs.

Silvestre JS, Kamsu-Kom N, Clergue M, Duriez M, Lévy BI.

J Pharmacol Exp Ther. 2002 Dec;303(3):1038-43.PMID: 12438525 [PubMed - indexed for MEDLINE]Related articlesFree article

Very-low-dose combination: a first-line choice for the treatment of hypertension?

Waeber B.

J Hypertens Suppl. 2003 Jun;21(3):S3-10. Review.PMID: 12929469 [PubMed - indexed for MEDLINE]Related articles

[Type 2 diabetes: blood pressure lowering to 135/75 mmHg reduces mortality]

Einecke D.

MMW Fortschr Med. 2007 Sep 20;149(38):18. German. No abstract available. PMID: 18018407 [PubMed - indexed for MEDLINE]Related articles

ADVANCE: breaking new ground in type 2 diabetes.

Chalmers J, Perkovic V, Joshi R, Patel A.

J Hypertens Suppl. 2006 Aug;24(5):S22-8.PMID: 16936533 [PubMed - indexed for MEDLINE]Related articles

[Cardioprotective effects of anti-hypertensive medications]

Asmar RG.

Curr Med Res Opin. 2005;21 Suppl 5:S17-21. French. PMID: 16197648 [PubMed - indexed for MEDLINE]Related articles

[Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke]

Masson C.

Presse Med. 2001 Nov 24;30(35):1716-7. French. No abstract available. PMID: 11775593 [PubMed - indexed for MEDLINE]Related articles

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B.

Lancet. 2007 Sep 8;370(9590):829-40.PMID: 17765963 [PubMed - indexed for MEDLINE]Related articles